Abstract

Social media platforms have become a popular source of information for real-time monitoring of events and user behavior. In particular, Twitter provides invaluable information related to diseases and public health to build real-time disease surveillance systems. Effective use of such social media platforms for public health surveillance requires data-driven AI models which are hindered by the difficult, expensive, and time-consuming task of collecting high-quality and large-scale datasets. In this paper, we build and analyze the Epidemic TweetBank (EpiBank) dataset containing 271 million English tweets related to six epidemic-prone diseases COVID19, Flu, Hepatitis, Dengue, Malaria, and HIV/AIDs. For this purpose, we develop a tool of ESS-T (Epidemic Surveillance Study via Twitter) which collects tweets according to provided input parameters and keywords. Also, our tool assigns location to tweets with 95% accuracy value and performs analysis of collected tweets focusing on temporal distribution, spatial patterns, users, entities, sentiment, and misinformation. Leveraging ESS-T, we build two geo-tagged datasets of EpiBank-global and EpiBank-Pak containing 86 million tweets from 190 countries and 2.6 million tweets from Pakistan, respectively. Our spatial analysis of EpiBank-global for COVID19, Malaria, and Dengue indicates that our framework correctly identifies high-risk epidemic-prone countries according to World Health Organization (WHO) statistics.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.